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 Chapter 20 
 Integrating Bio-ontologies and Controlled Clinical 
Terminologies: From Base Pairs to Bedside Phenotypes 
 Spiros  C.  Denaxas 
 Abstract 
 Electronic Health Records (EHR) are inherently complex and diverse and cannot be readily integrated and 
analyzed. Analogous to the Gene Ontology, controlled clinical terminologies were created to facilitate the 
standardization and integration of medical concepts and knowledge and enable their subsequent use for 
translational research, offi cial statistics and medical billing. This chapter will introduce several of the main 
controlled clinical terminologies used to record diagnoses, surgical procedures, laboratory results and medi-
cations. The discovery of novel therapeutic agents and treatments for rare or common diseases increasingly 
requires the integration of genotypic and phenotypic knowledge across different biomedical data sources. 
Mechanisms that facilitate this linkage, such as the Human Phenotype Ontology, are also discussed. 
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1  Introduction 
 We are arguably entering the era of data-driven, personalized med-
icine, where electronic health records are considered the transfor-
mational force for measuring and improving the quality of clinical 
care and accelerating the pace of biomedical research [ 1 ,  2 ]. 
Electronic Health Record (EHR) data, alternatively referred to as 
Electronic Medical Record (EMR) data, are broadly defi ned as 
electronic data that are generated, captured and collected as part of 
routine clinical care across primary, secondary, and tertiary health 
care settings. EHR data can be structured (i.e., recorded using 
clinical terminologies), semi-structured (e.g., laboratory test 
results), or unstructured (e.g., free text). EHR data present mul-
tiple opportunities that have the potential to transform medical 
practice and research across all stages of translation [ 3 – 6 ]. 
 Health care is an intrinsically multidisciplinary process and the 
care of patients, even within a single clinical specialty, intimately 
involves clinicians from a diverse set of other specialties (e.g., physi-
cians, surgeons, radiologists, pharmacologists). Patient  interactions 
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often occur within distinct health care settings: some diseases are 
almost exclusively managed in primary care while acute manifesta-
tions are usually treated in secondary care. For chronic conditions, 
such as cardiovascular diseases, patients may have multiple interac-
tions within primary and secondary care, and undergo assessments 
and diagnostic tests across both settings over long periods of time. 
The amount of EHR data being digitally generated and collected 
are thus vast and rapidly expanding but lack a common structure to 
facilitate their use, both for care across clinical settings but also for 
research, auditing, and other administrative purposes. 
 The purpose of this chapter is to provide a brief introduction 
to clinical terminologies for capturing and representing different 
aspects of clinical care in electronic health records. Firstly, contem-
porary terminologies for recording diagnoses, surgical procedures, 
lab measurements, and medication are described. Secondly, the 
main applications and challenges of using clinical terminologies are 
set out. Lastly, a potential pathway for integrating clinical termi-
nologies with biological ontologies is illustrated through a case 
study in breast cancer. 
2  Controlled Clinical Terminologies 
 Similar to bio-ontologies, such as the Gene Ontology [ 7 ,  8 ], con-
trolled clinical terminologies (Table  1 ) were created to facilitate 
the systematic capture, curation, and description of health care- 
related concepts encountered during clinical care [ 9 ]. These can 
include but are not limited to diagnoses, symptoms, anatomical 
terms of location, prescribed medications, medical tests, surgical 
procedures, and laboratory measurements. Clinical terminologies 
are considered the conceptual core of clinical information systems 
and an essential tool for facilitating clinical data integration and 
reuse amongst disparate data sources. Initiatives such as the Open 
Biomedical Ontologies Consortium (OBO) [ 10 ] were founded to 
coordinate their evolution and alignment and provide a set of 
guidelines for creating and maintaining them with the aim of estab-
lishing an ecosystem of interoperable entities.
 Several systematic literature reviews provide in-depth detail on 
their different aspects and characteristics [ 11 – 16 ]. A brief descrip-
tion of some key terminologies is provided below. 
 SNOMED-Clinical Terms (SNOMED-CT) [ 17 ,  18 ] contains repre-
sentations for over 300,000 health care-related concepts and is 
designed to capture and represent patient data for clinical care. It 
consists of four primary components that defi ne the structure of the 
recorded information: concepts, descriptions, relationships and refer-
ence sets.  Concepts are the basic unit of describing health care- related 
information and are uniquely identifi ed, e.g., the  Myocardial 




Fully Specifi ed Name, a list of Preferred Terms (e.g., Myocardial 
Infarction), and Synonyms (e.g., Heart attack, Cardiac infarction) 
defi ned. Concepts are organized into an acyclic hierarchy of is-a rela-
tionships that enables multiple inheritance i.e. concepts can have 
 Table 1 
 Common clinical terminologies, classifi cation systems, and ontologies used in electronic health records 
 Terminology  Information 
 CPT  Name : Current Procedural Terminology 
 Context : surgical procedures 
 Website :  http://www.ama-assn.org/go/cpt 
 DSM-5  Name : Diagnostic and Statistical Manual of Mental Disorders—version 5 
 Context : mental health diagnoses 
 Website :  http://www.dsm5.org/ 
 ICD-10  Name : International Statistical Classifi cation of Diseases and Related Health 
Problems—10th revision 
 Context : diagnoses 
 Website :  http://www.who.int/classifi cations/icd/en/ 
 LOINC  Name : Logical Object Identifi ers and Codes 
 Context : laboratory measurements 
 Website :  https://loinc.org/ 
 MedDRA  Name : Medical Dictionary for Regulatory Activities 
 Context : biopharmaceutical regulation 
 Website :  http://www.meddra.org/ 
 MeSH  Name : Medical Subject Headings 
 Context : life sciences literature indexing 
 Website :  https://www.nlm.nih.gov/mesh/ 
 NCIT  Name : National Cancer Institute Thesaurus 
 Context : biomedical concepts related to cancer 
 Website :  http://ncit.nci.nih.gov/ 
 OPCS  Name : OPCS Classifi cation of Interventions and Procedures 
 Context : surgical procedures 
 Website :  http://systems.hscic.gov.uk/data/clinicalcoding/codingstandards/opcs4 
 Read  Name : Read Codes, Clinical Terms 
 Context : all health care related concepts 
 Website :  http://systems.hscic.gov.uk/data/uktc/readcodes 
 RxNorm  Name : RxNorm 
 Context : US clinical drugs 
 Website :  http://www.nlm.nih.gov/research/umls/rxnorm/ 
 SNOMED-CT  Name : Systematized Nomenclature of Medicine-Clinical Terms 
 Context : all health care related concepts 
 Website :  http://www.ihtsdo.org/snomed-ct 
 UMLS  Name : Unifi ed Medical Language System 
 Context : clinical terminology mappings 
 Website :  http://www.nlm.nih.gov/research/umls/ 
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multiple parent concepts. For example  Myocardial Infarction (id 
22298006) is a subclass of the concepts  Necrosis of anatomical 
site (id 609410002),  Ischaemic heart disease (414545008), and 
 Myocardial disease (id 57809008). SNOMED-CT contains terms 
for describing clinical fi ndings, symptoms, diagnoses, procedures, 
medication, devices and anatomical body structures. It provides a 
compositional syntax which allows multiple ontology terms to be 
combined in order to build composite terms to represent complex 
medical concepts, a process known as post-coordination. Signifi cant 
variation exists internationally with regards to SNOMED-CT adop-
tion and implementation [ 19 ] and its use for research or routine clini-
cal care. In the UK National Health Service (NHS), SNOMED-CT 
has been designated to become the standard clinical terminology to 
be used across the entire health care system by 2020. 
 The International Statistical Classifi cation of Diseases and 
Related Health Problems (ICD) is a statistical classifi cation system 
maintained by the World Health Organization [ 20 ]. ICD encapsu-
lates concepts for classifying diseases, signs and symptoms, abnormal 
investigation fi ndings, complaints, interactions with the health care 
system, social circumstances, and external causes of injury or disease. 
It maps health conditions to corresponding generic categories 
together with specifi c variations, assigning for these a designated 
alphanumeric code, up to six characters long. Major categories are 
designed to include a set of similar diseases (e.g., ICD chapter “I” 
encapsulates all diseases of the circulatory system). It is currently the 
most widely used statistical classifi cation system in the world with 
many countries developing their own extensions and modifi cations 
tailored to their local health care system (e.g., ICD- 9- CM used in 
the USA [ 21 ]). The primary use case of ICD is to abstract EHR data 
by assigning unique codes to diagnoses and procedures. This pro-
cess is known as  clinical coding , and performed manually or algorith-
mically by specialist staff according to a prespecifi ed protocol. Coded 
data are then utilized for research [ 22 ], offi cial statistics [ 23 ], medi-
cal billing, and health care resource planning. 
 Clinical terminologies are used for describing surgical procedures, 
interventions, and investigations that patients undergo in hospi-
tals, during in patient and outpatient interactions. In the USA, the 
American Medical Association maintains the Current Procedural 
Terminology [ 24 ] (CPT) and in the UK, the OPCS Classifi cation 
of Interventions and Procedures version 4 (OPCS-4) [ 25 ] is used 
by the National Health Service. Both terminologies are used to 
convey information with regards to procedures to physicians and 
clinical coders and are combined with diagnosis codes during the 
medical billing process. 
 Logical Observation Identifi ers Names and Codes (LOINC) [ 26 – 28 ] 
is maintained by the Regenstrief Institute and used for describing 
medical laboratory observations. LOINC facilitates the exchange of 
2.2  Procedures




information with regards to laboratory tests and results between 
health care providers, laboratories and public health agencies. 
LOINC terms correspond to a single test, panel, observation, or 
measurement and are uniquely identifi ed by a numeric code. Terms 
are formed of six parts: component (what is being measured), prop-
erty (characteristics of what is being measured), time (measurement 
temporal information), system (observation context or specimen 
type), scale (scale of measure), and method (procedure used to 
obtain the measure). 
 RxNorm [ 29 ] is a US-specifi c terminology developed by the Library 
of Medicine for describing information about clinical drugs (defi ned 
as pharmaceutical products taken by patients with a therapeutic or 
diagnostic intent). It provides normalized names for all clinical drugs 
and links information about their active ingredient(s), strengths, 
form, and branded versions. RxNorm is widely used for recording 
drug information in patient health records, exchanging information 
between health care providers [ 30 ], personal medication records 
[ 31 ], and medication-related clinical decision support [ 32 ] and con-
tains cross-references to other commonly used drug vocabularies. 
3  Uses of Clinical Terminologies 
 While clinical terminologies are primarily used for the purposes of 
clinical data standardization and integration, the provision of a sys-
tematic and common language for describing health care concepts 
enables the subsequent use of EHR data for a diverse set of pur-
poses, such as clinical research, auditing and billing. Adoption of 
clinical terminologies worldwide varies across health care settings 
and by purpose but diagnostic and procedural classifi cation sys-
tems are primarily used for medical billing purposes. This section 
will briefl y describe the opportunities and challenges of using EHR 
data and clinical terminologies. 
 EHR data are increasingly being linked and used for translational 
research [ 33 ] as they offer larger sample sizes at a higher clinical 
resolution [ 34 ]. A primary use-case of linked EHR data is to accu-
rately extract phenotypic information (i.e., disease status), a process 
known as  phenotyping [ 35 ]. Identifying cohorts of patients that 
share a common characteristic (e.g., have been diagnosed with 
hypertension or have abnormally high blood glucose measure-
ments) enables researchers to use EHR data to perform large-scale 
clinical research studies at a lower cost compared to traditional 
bespoke investigator-led studies. EHR data have been used to 
examine disease aetiology in relation to clinical risk factors [ 36 ,  37 ] 
or genotypic information [ 38 ,  39 ], develop disease prognosis mod-
els [ 40 ], perform health outcome comparisons between countries 
2.4  Medication
3.1  Opportunities
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[ 41 ], and facilitate pragmatic clinical trials [ 24 ]. Clinical terminolo-
gies are heavily used by deterministic rule-based algorithms curated 
by experts for identifying and constructing patient cohorts from 
raw EHR data but data-driven methodologies are increasingly 
being utilized [ 42 ]. Comprehensive reviews provide additional 
information on the use of clinical terminologies for other purposes 
such as annotating and accessing medical knowledge sources, data 
integration, semantic interoperability, data aggregation, and clinical 
decision support systems [ 43 – 46 ]. 
 Merging EHR data across sources becomes challenging due to the 
differences in the manner in which data are recorded. Each health 
care setting generates and records data for a particular purpose 
using the clinical terminology that is optimal in that specifi c con-
text. For example, information in primary care can be recorded 
using SNOMED-CT whereas hospital morbidities would be 
recorded using ICD-10. This mismatch between the clinical termi-
nologies used to record information leads to signifi cant challenges 
as information is recorded at varying levels of granularity across 
sources. Semantic mapping systems, such as the Unifi ed Medical 
Language System [ 47 ] (UMLS), can provide further details on the 
relationship between terms in each clinical terminology and facili-
tate the translation or integration of information across sources. 
However, direct one-to-one mappings might not always exist 
between terminologies leading to information loss due to insuffi -
cient resolution or confl icts between two sources where multiple 
potential mappings exist. These issues and their severity vary by 
clinical speciality and context but often require a set of rules to be 
created by users and manually applied in order to resolve them 
before the data can be used for research purposes. In cases of 
incomplete mappings, synonyms or adjacent terms in the clinical 
terminology might be used as a replacement term but that is 
assessed on a case-by-case basis. 
4  Integrating Biological and Clinical Data 
 A key challenge in genomics is to understand and elucidate the phe-
notypic consequences of variation observed in the genotypic level. 
Even among Mendelian diseases, the association between genotype 
and phenotype is often complex. With the advent of next-genera-
tion sequencing methods, the focus is now shifting from generating 
genomic sequence data to effi ciently interpreting them. 
 From a clinical care perspective, diseases presented by patients 
can be phenotypically distinct and associated with a specifi c set of 
treatments, symptoms, investigative procedures and management 
strategies. From a molecular scientist’s perspective however, it might 
be appropriate to group and analyze diseases that share a common 




in the way they manifest in different patient groups. Both of these 
viewpoints are valid, but as a direct consequence, data describing 
phenotypic and molecular properties are recorded in a different, and 
often incompatible, manner [ 48 ]. The problem is exacerbated in 
rare diseases where researchers are required to create larger cohorts 
of patients by pooling data across research consortia in order to 
increase the sample sizes and obtain accurate estimates of risk. 
 Increasing amounts of molecular function knowledge are being 
recorded in a hierarchical manner, using bio-ontologies such as the 
GO, which offer a rigid way to represent knowledge in a machine-
readable manner, interoperable between different data sources and 
annotated [ 11 ]. Scientists aim to link and integrate this with pheno-
typic information in order to elucidate the genotype- phenotype 
relationship and facilitate the discovery of novel therapeutic agents 
and treatments for common or rare disorders. Ontologies such as 
the Human Phenotype Ontology (HPO) [ 49 ,  50 ] and the Disease 
Ontology [ 51 ,  52 ] were created to provide streamlined disease defi -
nitions by systematically combining the diverse and heterogeneous 
knowledge contained within clinical terminologies and other anno-
tation sources under a single framework. These tools aim to provide 
researchers with a rich resource that semantically links diverse dis-
ease defi nitions from clinical terminologies and enables the linking 
of phenotypic, genotypic and genetic information of a disease. 
 The HPO is a structured, curated ontology describing phenotypic 
abnormalities and the relationships between them. The HPO aims to 
act as scaffolding for enabling the interoperability between molecular 
biology and human disease by providing a centralized resource for 
integrating genotypic and phenotypic data across biomedical sources. 
The HPO enables the computational analysis of human (and model 
organism) phenotypes against the background biological and molecu-
lar knowledge incorporated in biological ontologies such as the GO. 
 The HPO is organized as three independent sub-ontologies that 
cover different domains with the largest one being the one describ-
ing phenotypic abnormalities. The other two sub- ontologies describe 
the mode of inheritance and the onset and clinical course of the 
abnormalities. The primary focus of the HPO is not to capture dis-
eases but rather the phenotypic abnormalities that are associated 
with them. Each HPO term describes a phenotypic abnormality 
(e.g.,  Primary congenital glaucoma ) and is assigned a unique persis-
tent identifi er (e.g.,  HP:0001087 ). HPO terms are related to parent 
terms by “is a” relationships and terms can have multiple parent 
terms. The HPO is not primarily designed to capture and document 
quantitative information (e.g., systolic blood pressure, body mass 
index) but does provide qualitative descriptions of excess or reduc-
tion in quantity leading to a phenotypic abnormality (e.g., markedly 
reduced T cell function). 
 Interoperability between molecular and phenotypic data and 
research areas is accomplished through a comprehensive set of term 
4.1  Human 
Phenotype Ontology
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annotations. The majority of HPO terms contain a reference to the 
Unifi ed Medical Language System [ 47 ], enabling the mapping of 
terms between controlled clinical terminologies and other sources 
in the UMLS Metathesaurus. Additionally, HPO terms contain 
annotations that provide pointers to specifi c diseases or genes cre-
ated in other external knowledge sources such as Online Mendelian 
Inheritance in Man (OMIM) database ( http://omim.org/ ), 
DECIPHER ( https://decipher.sanger.ac.uk/ ), and Orphanet 
( http://www.orpha.net/ ). HPO annotations have a number of 
metadata fi elds associated with them for further specifying onset, 
frequency and quantifying modifi er effects. Annotations evidence 
codes, analogous to GO Evidence Codes, describe the manner in 
which a particular annotation was assigned to a term (e.g., inferred 
by text mining, traceable author statement, inferred from electronic 
annotation, public clinical study). 
 Using malignant neoplasms of the breast as a hypothetical case 
study, this section presents a potential pathway of linking biologi-
cal knowledge on genotypic variation and molecular functions to 
clinical phenotypes encountered within the health care system. 
Drilling down from the right-hand side of clinical phenotypes 
down to the left-hand side of genotypic variation, 
 Figure  1 illustrates details of all potential sources and annota-
tion mechanisms used within each source to capture and record 
information.
 Genotypic information : HPO annotations provide a cross-link to the 
Online Mendelian Inheritance in Man (OMIM)  Breast Cancer, 
Familial phenotype entity (OMIM #114480—URL  www.omim.
org/entry/114480 ). OMIM provides curated lists of disease phe-
notypes and genes associated with that phenotype, in this case for 
example the BRCA2 gene entry (OMIM *600185— www.omim.
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 Fig. 1  Along one potential path from genomic variation to genotypic information, transcripts and phenotypic 
information observed in clinical care there are multiple annotation mechanisms that are being utilized to 





org/entry/600185 ). Additionally, entries provide cross- links with 
Entrez [ 53 ] (Gene ID 675—URL  http://www.ncbi.nlm.nih.gov/
gene/675 ) and Ensembl [ 54 ] (ENSG00000139618—URL 
 http://www.ensembl.org/Homo_sapiens/Gene/Summary?g=EN
SG00000139618;r=13:32315474-32400266 ).  Breast Cancer 2, 
early onset ( BRCA2 ) is a protein-coding gene and belongs to the 
Fanconi anemia, complementation group (FANC) family of genes. 
 Genotypic variation : The NCBI dbSNP ( http://www.ncbi.nlm.
nih.gov/SNP/ ) provides curated and annotated information link-
ing Single Nucleotide Polymorphisms (SNPs) and individual 
genes. rs144848 is one of the multiple mutations in the BRCA2 
gene that have been reported to represent an independently minor 
but cumulatively signifi cant increased risk for developing breast 
cancer [ 55 ]. dbSNP provides information the SNPs location (e.g., 
chromosome and chromosomal position), source assays, discor-
dant genotypes and population diversity. (URL  http://www.ncbi.
nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=rs144848 ) 
 Molecular function : UniProt [ 56 ] provides information on gene 
transcripts, in this case BRCA2_HUMAN (P51587, Breast cancer 
type 2 susceptibility protein). The biological process and molecular 
functions of the gene product are annotated using the Gene 
Ontology:  double-strand break repair via homologous recombination 
(GO:0000724),  DNA Repair (GO:0006281),  cytokinesis 
(GO:0000910),  protease binding (GO:0002020), and positive reg-
ulation of transcription, DNA-templated (GO:0045893). Using 
the GO, researchers are able to identify other gene products that 
share a common biological pathway or molecular function and 
incorporate that knowledge in their experiments. (URL:  http://
www.uniprot.org/uniprot/P51587 ) 
 Phenotypic information : The HPO  Breast carcinoma term (HP: 
0003002— http://purl.obolibrary.org/obo/HP_0003002 ) defi nes 
the presence of a carcinoma of the breast and is a child node of 
 Neoplasms of the breast (HP:0100013). The HPO term contains a 
cross-reference to the Unifi ed Medical Language System (UMLS) 
 Malignant Neoplasm of Breast (UMLS:C0006142—URL  https://
uts.nlm.nih.gov//metathesaurus.html#C0006142;0;1;CUI;2015AA
;EXACT_MATCH ;*;)  Concept which in turns provides mappings to 
other major controlled clinical terminologies such as the International 
Classifi cation of Diseases 10th revision (C50, Malignant neoplasm of 
breast— http://apps.who.int/classifications/icd10/browse/
2010/en#/C50-C50 ) and SNOMED- Clinical Terms (254837009, 
Malignant tumor of breast— http://bioportal.bioontology.org/
ontologies/SNOMEDCT?p=classes&conceptid=254837009 ). 
 Clinical phenotype : Oncology data in hospitals are stored in diverse 
locations and formats since diagnosis and treatment is a multidisci-
plinary process between pathology, radiology, surgery, medical 
Integrating Bio-ontologies and Controlled Clinical Terminologies: From Base Pairs…
284
oncology and radiotherapy. Breast cancer diagnosis and severity is 
usually evaluated through imaging tests such as mammograms, 
ultrasounds, magnetic resonance imaging or by performing a 
biopsy. Medical images and their associated metadata are stored in 
a picture archiving and communication system (PACS) system and 
information about these procedures and the results obtained would 
be recorded using intervention and procedure terms. Diagnosis and 
staging information would be stored and coded in pathology sys-
tems using a medical terminology such as SNOMED-CT or other 
bespoke data structures. Treatment data would be stored in the 
pharmacy information systems. 
5  Conclusion 
 The amount of clinical data that are generated and captured during 
routine clinical care is increasing in size and complexity. Integrating 
clinical data from disparate sources however is a challenging task due 
to their lack of common structure and annotation. Similar to the 
Gene Ontology, controlled clinical terminologies have been created 
to facilitate the systematic capture, curation, and description of health 
care related events such as diagnoses, prescriptions and procedures 
from EHR data and enable their subsequent usage for clinical care, 
research, or administrative purposes. Furthermore, linking EHR data 
with biological knowledge is increasingly becoming possibly through 
tools such as the Human Phenotype Ontology (HPO) and the 
Disease Ontology that aim to provide the semantic  scaffolding for 
computationally integrating biomedical knowledge across sources. 
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